Medicare AdvantagePrior AuthMedium impact
MA08.150a, Intravenous (IV) Iron Preparations
Independence Blue Cross·Hematology, Nephrology, Oncology +1 more·Medical Policy
Effective date
Mar 23, 2026
We identified it
Jun 19, 2026
Summary
MA08.150a updates medical necessity criteria for intravenous (IV) iron preparations effective March 23, 2026. This policy change affects Medicare Advantage coverage and billing requirements for IV iron treatments. The billing team must review the full policy text to identify specific documentation, prior authorization, or coding requirement changes.
Action Required
By March 23, 2026: Billing team must obtain and review the complete MA08.150a policy text from the provided URL to identify specific medical necessity criteria, prior authorization requirements, and affected HCPCS codes (likely J-codes for IV iron products). Update billing software rules, prior authorization workflows, and provider documentation templates accordingly. Providers should document medical necessity per updated criteria. Contact the plan (IBX) if full policy details are not accessible. Claims submitted without compliance to updated criteria will be denied effective 03/23/2026.